Versatile complex amine synthesis via aziridinium ylides and 2-amidoallyl cations

NIH RePORTER · NIH · R01 · $288,880 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract: Efficient access to molecules of importance to human health has long driven the development of innovative synthetic methods. In recent years, greater emphasis has been placed on explorations of stereochemically complex molecular space not well-represented in typical compound screening libraries. In this context, N- heterocycles and aminated carbocycles are particularly attractive targets, as they are prevalent in drugs, natural products, biomolecules, and ligands. A unified and modular platform capable of rapid, flexible transformations of a simple set of precursors into azetidines, pyrrolidines, piperidines and amine-bearing carbocycles could speed drug discovery processes in complex amine chemical space. Our premise is that developing general, stereoselective routes to aziridinium ylides and 2-amidoallyl cations, coupled with the ability to divert reactivity of these key intermediates along multiple pathways, will provide a versatile approach to diverse, densely functionalized stereochemically complex N-heterocycles comprising useful bioactive chemical space. In addition to the development of new synthetic methods, biological testing of chemical space unlocked by our proposed work is critical to its long-term significance. Our program centered on new oxidative allene amination methods for the synthesis of densely functionalized and heavily substituted amine motifs has yielded ~500 novel amines that have been submitted to the Eli Lilly Open Innovation Drug Discovery (OIDD) program, as well as other academic and industrial collaborators. Promising results showing a broad range of bioactivities in the amine space covered by this preliminary library. This proposal aims to add even more powerful and versatile methods for the syntheses of complex amines from a set of modular, simple building blocks. All new compounds synthesized in the course of these studies will be submitted for screening through OIDD, the UW- Madison Medicinal Chemistry Center and other academic and industrial programs.

Key facts

NIH application ID
9921424
Project number
5R01GM132300-02
Recipient
UNIVERSITY OF WISCONSIN-MADISON
Principal Investigator
Jennifer Marie Schomaker
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$288,880
Award type
5
Project period
2019-05-01 → 2023-03-31